₹5,000 Monthly SIP in Nippon India Pharma Fund-Growth Plan for 5 Years
If you had started a ₹5,000/month SIP on 28 Sept 2021 and never stopped — through every crash and rally — here is exactly what happened, using Nippon India Pharma Fund-Growth Plan's actual NAV for all 61 installments.
You invested
₹3,05,000
61 installments
Value today
₹4,59,856
28 Sept 2026
Absolute gain
+₹1,54,856
+50.8%
XIRR (annualised)
16.21%
money-weighted
The journey, month by month
Worst fall on the way
-13.4%
Deepest drop from peak. This is what you had to sit through.
Corrections survived
1
Falls of 10%+ during the period. Every one recovered.
Same SIP in a fixed deposit
₹3,59,106
Modelled at historical FD rates. The fund beat FD by ₹1,00,750.
Year-by-year progress
| Year | Invested | Value | Overall gain |
|---|---|---|---|
| Year 1 (28 Sept 2022) | ₹65,000 | ₹62,350 | -4.1% |
| Year 2 (29 Sept 2023) | ₹1,25,000 | ₹1,51,786 | +21.4% |
| Year 3 (30 Sept 2024) | ₹1,85,000 | ₹3,00,643 | +62.5% |
| Year 4 (29 Sept 2025) | ₹2,45,000 | ₹3,45,704 | +41.1% |
| Year 5 (28 Sept 2026) | ₹3,05,000 | ₹4,59,856 | +50.8% |
Best year of the journey: Year 3 (+42% market move) · Toughest year: Year 4 (-4.1%)
Wealth Time Machine
Watch this exact journey as a 60-second cinematic replay
Every crash headline, every recovery — with your money in it.
Try a different amount
Try a different duration
Past performance does not guarantee future returns. This page shows the historical result of the stated SIP using Nippon India Pharma Fund-Growth Plan's published NAV (source: AMFI) between 28 Sept 2021 and 28 Sept 2026; it is educational research, not investment advice. FD comparison is modelled at historical average FD rates. Mutual fund investments are subject to market risks.